In recent years, research has helped drastically improve survival rates for people living with cancer. But despite these advances, we still have a long way to go to achieve our goal of finding cures for all cancers.
To achieve this goal, we will need to develop new technologies that will help us better understand cancer and treat cancer more effectively. Amongst these new technologies are better imaging tools that will allow us to see and treat cancers more precisely, artificial intelligence tools that will help us gain better insight into the unique nature of each person’s disease and MRI and Ultrasound tools that will help focalize treatments to enhance drug penetration and avoid negative side effects.
Today, the negative side-effects associated with certain treatments and our inability to cure hard-to-treat cancers make investing in the development of new technologies a pressing issue for cancer researchers.
Our Research Strategy
At the Terry Fox Research Institute, we are bringing together the best researchers from the country's top cancer institutions to work on projects that are helping to develop cutting-edge technologies that will revolutionize cancer research and care.
In 2018/19, roughly 7.2 per cent of the money invested by the TFRI supported blood cancer research. This added up to a total investment of $1.9 million.*
To allocate our resources, we ask international experts to evaluate the excellence and the potential for impact of all our research projects. This approach distinguishes our research investment strategy from all others in Canada and allows donors to be confident that their investment is supporting the top 5% of Canadian researchers and their science.
*Our scientific discovery projects are interdisciplinary by design and often focus on more than one cancer type. The figures listed above are an estimate and should not be taken as exact figures.